Q&A: Achieving Reagent-Free Blood Analysis With Optical Spectroscopy
A Q&A with Olga Pawluczyk, President and CEO, P&P Optica
P&P Optica Inc. (Waterloo, ON, Canada) burst onto the optical spectroscopy scene earlier this year after receiving a major technology development award from the Canadian government. Olga Pawluczyk, president of P&P Optica, is one of the key innovators involved in the success of the company's technology. In this Q&A, Pawluczyk introduces us to a new spectroscopy-based approach to reagent-free blood analysis that her company is in the final stages of developing. She explains how the technology works, discusses the impact it will have on the blood analysis market, and explores future applications for it in the biomedical arena.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Photonics Online? Subscribe today.